Applying insurance principles to reimbursement models for novel antibiotics

The lack of financial incentives associated with developing novel antibiotics has resulted in limited innovation in this area, though it is needed. In this presentation, Milliman’s Joanne Buckle and Tanya Howard explore how the principles of insurance can be applied to structure reimbursement models for novel antibiotics, and ultimately stimulate innovation while offering financial protection to payers.

Leave a Reply

Your email address will not be published. Required fields are marked *